Controversy mounts over plan to re-categorize drugs

Published: 2012-06-05 07:00:00

Updated: 2012-06-05 07:00:00

Tension is escalating between doctors and pharmacists over the government's plan to "re-categorize" medicines as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.

The Korea Food and Drug Association (KFDA) plans to announce its re-catego...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK